Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Recruitment to activated tyrosine kinase growth factor receptors of Grb2 and p21(ras) leads to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk). Activated Erk phosphorylates specific serine residues within cytosolic phospholipase A(2) (PLA(2)), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA). In the A549 human adenocarcinoma cell line dexamethasone inhibited epidermal growth factor (EGF)-stimulated cytosolic PLA(2) (cPLA(2)) activation and AA release by blocking the recruitment of Grb2 to the activated EGF receptor (EGF-R) through a glucocorticoid receptor (GR)-dependent (RU486-sensitive), transcription-independent (actinomycin-insensitive), mechanism. The dexamethasone-induced block of Grb2 recruitment was parallelled by changes in phosphorylation status and subcellular localization of lipocortin 1 (LC1) and an increase in the amount of the tyrosine phosphoprotein co-localized with EGF-R. Like dexamethasone, peptides containing E-Q-E-Y-V from the N-terminal domain of LC1 also blocked ligand-induced association of Grb2, p21(ras) and Raf. Our results point to an unsuspected rapid effect of glucocorticoids, mediated by occupation of GR but not by changes in gene transcription, which is brought about by competition between LC1 and Grb2 leading to a failure of recruitment off signalling factors to EGF-R
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of glucocorticoids to GR not only activates the receptor, but also liberates accessory proteins that participate in secondary signaling cascades.”
From Corticosteroids (2016) · cites this paper as [38]
In the citing paper
“For example, when released from the inactive GR protein complex, c-Src activates signaling cascades that inhibit phospholipase A2 activity, phosphorylate annexin 1, and impair the release of arachidonic acid38, 39.”
From Corticosteroids (2016) · cites this paper as [38]
Citations
Cites
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L.-L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,849 · cited 1×
“Activated Erk phosphorylates speci®c serine (Ser) residues within cytosolic phospholipase A2 (cPLA2), promoting enzyme translocation to membranes and facilitating liberation of arachidonic acid (AA) (Lin et al., 1993).”
BackgroundDNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“A recent study, for example, showed that, in contrast to the lethal nature of a GR knock-out, mice bearing a mutation of the GR which disabled dimerization, and hence GRE binding, survived (Reichardt et al., 1998).”
ResultTyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells.
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 959 · cited 1×
“Moreover, direct regulation of signalling mechanisms also appears to be a feature of the action of other steroid receptors, such as that for oestradiol (Migliaccio et al., 1996), and other nuclear hormone receptors (Bost et al., 1997).”
BackgroundMolecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids
BAMBERGER, C. M., SCHULTE, H. M., & CHROUSOS, G. P. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-3-245 · Cited by 889 · cited 1×
“The unactivated (unligated) GR is retained in the cytoplasm as a multi-protein complex consisting of heat shock proteins (hsp) (Bamberger et al., 1996) and several kinases of the MAPK signalling system, including Src (Pratt, 1998).”
BackgroundHeck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H. J., Herrlich, P., & Cato, A. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06726.x · Cited by 522 · cited 1×
“The inference was that other transcriptional activators such as AP1 and NFkB, which are probably bound by the GR monomer (Heck et al., 1994), play a key role in mediating the action of glucocorticoids.”
BackgroundMultiple components in an epidermal growth factor-stimulated protein kinase cascade
Ahn, N. G., Seger, R., Bratlien, R. L., Diltz, C. D., Tonks, N. K., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64310-1 · Cited by 492
Pratt, W. B. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44252 · Cited by 447 · cited 12×
“We show here that both GR and Src are rapidly released from the hsp90 complex in A549 cells following treatment by dexamethasone.”
BackgroundInfluentialInvolvement of p21ras in activation of extracellular signal-regulated kinase 2
de Vries-Smits, A. M. M., Burgering, B. M. T., Leevers, S. J., Mar shall, C. J., & Bos, J. L. (1992) · Nature · doi:10.1038/357602a0 · Cited by 387 · cited 1×
“…adapter protein Grb2 and the small GTPase p21ras initiates transduction of the mitogenic signalling mechanisms leading to downstream activation of the kinases Raf, MAPK/Erk kinase (Mek) and, subsequently, extracellular signal-regulated kinase (Erk) (Ahn et al., 1991; de Vries-Smits et al., 1992).”
BackgroundNuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
Caelles, C., González-Sancho, J. M., & Muñoz, A. (1997) · Genes & Development · doi:10.1101/gad.11.24.3351 · Cited by 334 · cited 1×
“Recently, other groups have implicated Jnk as an important mediator in A549 cell proliferation (Bost et al., 1997) and suggested that there is cross-talk between this pathway and activation of nuclear hormone receptors (Caelles et al., 1997).”
Background
Cited by
Items 201–300 of 330
Smyth, T., Harris, H. J., Brown, A., Tötemeyer, S. S., Farnfield, B. A., Maskell, D. J., Matsumoto, M., Plevin, R. J., Alldridge, L. C., & Bryant, C. E. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02307.x · Cited by 15
Naumann, L., Feist, E., Straub, R. H., Burmester, G., & Buttgereit, F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.045 · Cited by 13
Differential modulation of glucocorticoid action by FK506 in A549 cells
Croxtall, J. D., Paul‐Clark, M. J., & van Hal, P. T. W. (2003) · Biochemical Journal · doi:10.1042/bj20030821 · Cited by 13
Self-citationNefecon (Targeted-Release Formulation-Budesonide) for the Treatment of IgA Nephropathy
Vecchio, L. D., Rimoldi, C., & Pozzi, C. (2021) · Future Rare Diseases · doi:10.2217/frd-2021-0013 · Cited by 14
Glucocorticoid receptor and RAS: an unexpected couple in cancer
Cirstea, I. C., Moll, H. P., & Tuckermann, J. P. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.11.002 · Cited by 16
Kydd, A. S., Reno, C. R., Sorbetti, J. M., & Hart, D. A. (2005) · PubMed · Cited by 12
Kharwanlang, B., & Sharma, R. (2011) · PubMed · Cited by 14
Ahsan, M. K., Figueroa‐Hall, L. K., Baratta, V. M., García-Milian, R., Lam, T. T., Hoque, K. M., Salas, P. J. I., & Ameen, N. A. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00076.2020 · Cited by 13
“In contrast, nongenomic regulation involves rapid cellular changes resulting from specific interactions with membrane-associated proteins and receptors and the release of proteins from the cGCR complex (16, 46) that does not involve modulation of gene expression.”
BackgroundMacrophage biology in the Anx-A1−/− mouse
Yona, S., Ward, B. J., Buckingham, J. C., Perretti, M., & Flower, R. J. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.10.008 · Cited by 11
Self-citationKapojos, J. J., van den Berg, A., Borghuis, T., Banas, B., Huitema, S., Poelstra, K., & Bakker, W. W. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.008 · Cited by 11
Corticosteroids, Kounis Syndrome and the Treatment of Refractory Vasospastic Angina
Koutsojannis, C. M., Cn, M., & Kounis, N. G. (2004) · Circulation Journal · doi:10.1253/circj.68.806 · Cited by 11
Glucocorticoid-induced ocular hypertension: origins and new approaches to minimize
Yorio, T., Patel, G. C., & Clark, A. F. (2020) · Expert Review of Ophthalmology · doi:10.1080/17469899.2020.1762488 · Cited by 9
Revolutionizing IBD therapy: Insights into contemporary treatment strategies
Kushwaha, P., Qureshi, R., Khan, N., & Mukhopadhyay, S. (2025) · International Reviews of Immunology · doi:10.1080/08830185.2025.2563522 · Cited by 14
“The c-Src activates multiple kinase cascades (PI3K, AKT, and MAPKs) leading to phosphorylation of annexin 1 and inhibition of cytosolic phospholipase A2 activity, thus impairing the release of inflammatory intermediate arachidonic acid [35].”
Uso sistémico de corticosteróides: revisión de literatura
Clarissa, F., Bolzani, B., Stefani, M., Charlín, R., Líbia, A., Pereira, C., & César, R. M. (2007) · Revista Medicina Cutánea Ibero-Latino-Americana · Cited by 54
Smit, P., Neumann, H. A. M., & Thio, H. B. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04449.x · Cited by 10
Liu, J., Zheng, K., Dong, L., Lin, J., Zhang, C., Xie, Y., & Wang, Y. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003160 · Cited by 13
“Additionally, this complex has been shown to enhance the expression of the Lipocortin-1 gene, which inhibits inflammation by reducing the release of arachidonic acid [ 65 ] .”
Cazzola, M., Pasqua, F., Ferri, L., Biscione, G. L., Cardaci, V., & Matera, M. G. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.08.005 · Cited by 9
Galindez, S. M., Keightley, A., & Koulen, P. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02585-7 · Cited by 10
“The pathway leads to the downstream phosphorylation of cytosolic phospholipase A2 and consequent liberation of arachidonic acid and pro-inflammatory proteins [22, 23].”
BackgroundInfluentialGannon, A., Darbey, A. L., Chensee, G., Lawrence, B. M., O’Donnell, L., Kelso, J., Reed, N., Parameswaran, S., Smith, S. E., Smith, L. B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315015 · Cited by 9
“Glucocorticoids control fundamental processes in the human body including cell metabolism [33], growth [34], differentiation [35], apoptosis and inflammation [36]).”
BackgroundGenomic and non-genomic effects of glucocorticoids in respiratory diseases
Lee, Z.-Y., & Tran, T. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.04.006 · Cited by 11
The Use of Albuterol/Budesonide as Reliever Therapy to Reduce Asthma Exacerbations
Panettieri, R. A., Chipps, B. E., SKOLNIK, N., George, M., Murphy, K. R., & Lugogo, N. L. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.01.043 · Cited by 10
The Simplified Science of Corticosteroids for Clinicians
Kaplan, D. J., Haskel, J. D., Kirby, D. J., Bloom, D. A., & Youm, T. J. (2020) · JBJS Reviews · doi:10.2106/jbjs.rvw.20.00038 · Cited by 9
Glucocorticoid Signaling in Health and Disease
Smoak, K. A., & Cidlowski, J. A. (2007) · Neuroimmune biology · doi:10.1016/s1567-7443(07)00203-7 · Cited by 14
Buttgereit, F., Seibel, M. J., & Bijlsma, J. W. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04404-2.10087-9 · Cited by 9
Gao, S., & Deviche, P. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.03.006 · Cited by 8
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
Cappetta, D., Bereshchenko, O., Cianflone, E., Rossi, F., Riccardi, C., Torella, D., Berrino, L., Urbanek, K., Angelis, A. D., & Bruscoli, S. (2021) · Cells · doi:10.3390/cells10082155 · Cited by 9
“Non-genomic effects are mainly characterized by a short delay of action and often involve modulation of intracellular signal-transduction cascades, such as phospholipases, cyclic AMP, protein kinases and calcium mobilization [17].”
BackgroundFrew, A. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00086-7 · Cited by 10
Buse, P., Maiyar, A. C., Failor, K. L., Tran, S. H., Leong, M. L. L., & Firestone, G. L. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.009 · Cited by 9
Mathematical modeling of immune modulation by glucocorticoids
Yakimchuk, K. (2019) · Biosystems · doi:10.1016/j.biosystems.2019.104066 · Cited by 8
Cytosolic Glucocorticoid Receptor-Interacting Proteins
Wikström, A. C., Widén, C., Erlandsson, A., Hedman, E., & Zilliacus, J. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_11 · Cited by 7
Mast Cells as Targets for Glucocorticoids in the Treatment of Allergic Disorders
Kassel, O., & Cato, A. C. B. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_10 · Cited by 7
Zahel, P., Bruggink, V., Hülsmann, J., Steiniger, F., Hofstetter, R. K., Heinzel, T., Beekmann, U., Werz, O., & Kralisch, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040504 · Cited by 6
van Stigt, A. C., Gualtiero, G., Cinetto, F., Dalm, V. A. S. H., IJspeert, H., & Muscianisi, F. (2024) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001032 · Cited by 6
Fugazzola, M. C., Barton, A. K., Niedorf, F., Kietzmann, M., & Ohnesorge, B. (2012) · BMC Veterinary Research · doi:10.1186/1746-6148-8-160 · Cited by 6
Oxidative Stress in Experimental Models of Acute Lung Injury
Mokrá, D., & Mokrý, J. (2019) · Springer eBooks · doi:10.1007/978-981-32-9366-3_2 · Cited by 9
Nocentini, G., Migliorati, G., & Riccardi, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-16056-6_4 · Cited by 7
Hallmann, A., Chomiczewska, A., Goździk, P., Leszczyńska, D., & Smolarz, K. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742150 · Cited by 5
Niegenomowy mechanizm działania glikokortykosteroidów
Grzanka, A., & Jarząb, J. (2009) · Advances in respiratory medicine · doi:10.5603/arm.27793 · Cited by 12
Yung, K. C., Xu, C. W., Zhang, Z. W., Yu, W. J., Li, Q., Xu, X. R., Han, Y. F., Wang, X. J., & Yin, J. (2020) · Hematology · doi:10.1080/16078454.2019.1710025 · Cited by 6
Scaldaferri, F., Petito, V., Lopetuso, L. R., Bruno, G., Gerardi, V., Ianiro, G., Sgambato, A., Gasbarrini, A., & Cammarota, G. (2013) · Mediators of Inflammation · doi:10.1155/2013/391473 · Cited by 5
Rapid Corticosteroid Actions on Behavior: Mechanisms and Implications
Gasser, P. J., Lowry, C. A., & Orchinik, M. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00041-3 · Cited by 9
Influence of Dexamethasone on Protease-Activated Receptor 2-Mediated Responses in the Airways
Saleh, S. M., Mann, T. S., Peters, T., Betts, R. J., & Henry, P. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132753 · Cited by 5
“Thus, although dexamethasone can, within minutes, inhibit key components in the signal transduction pathway leading to PGE2 synthesis in cell culture systems (Choudhury et al., 2000; Croxtall et al., 2000, 2002; Chivers et al., 2004), this effect was not evident in the intact airway preparations.”
BackgroundAmbrish, T., Jayaswamy, P. K., Haridas, V., Kellarai, A., Shetty, S., & Shetty, P. K. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104085 · Cited by 5
Janka-Junttila, M., Hasala, H., Adcock, I. M., Moilanen, E., & Kankaanranta, H. (2012) · Journal of Cell Death · doi:10.4137/jcd.s9097 · Cited by 4
Molecular Mechanisms of Glucocorticoids Action: From Basic Research to Clinical Implications
Liberman, A. C., Castro, C. N., Antunica-Noguerol, M., Tabarrozzi, A. E. B., Druker, J., Perone, M. J., & ARZT, E. S. (2010) · Current Immunology Reviews · doi:10.2174/1573395511006040371 · Cited by 4
Current application of dexamethasone-incorporated drug delivery systems for enhancing bone formation
Mai, T. P., Park, J., Nguyen, H. D., Min, K. A., & Moon, C. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00629-8 · Cited by 6
“This complex then moves to the nucleus and binds to several specific DNA sites, leading to stimulation and suppression of a wide range of gene transcription (Croxtall et al. 2000).”
BackgroundLipid malabsorption persists after weaning in rats whose dams were given GLP‐2 and dexamethasone
Iordache, C., Drozdowski, L. A., Clandinin, M. T., Wild, G., Todd, Z., & Thomson, A. B. R. (2005) · Lipids · doi:10.1007/s11745-005-1478-x · Cited by 4
Zhai, M., Chen, Y., Liu, C., Wang, J., & Yu, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9057 · Cited by 4
“The possible mechanism is that Dex functions independently, as demonstrated by Croxtall et al (37).”
Buckingham, J. C., & Flower, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00025-5 · Cited by 3
Self-citationDefining the Differential Corticosteroid Response Basis from Multiple Omics Approaches
Ramirez-Falcon, M., Suarez-Pajes, E., & Flores, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413611 · Cited by 5
Hou, W., Guan, J., Lu, H., Dong, Q., Han, Y., & Zhang, R. (2014) · Journal of Ovarian Research · doi:10.1186/s13048-014-0089-z · Cited by 3
“It is well known that DEX acts through glucocorticoid receptors (GRs) [50], however, the expressions of GRs were not evaluated in this study.”
BackgroundRetractedSong, W., Cao, H., Zhang, D., Xu, H., Zhang, Q., Wang, Z., Li, S., Wang, W., Hu, W., Wang, B., et al. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01044-4 · Cited by 3
Diclofenac and dexamethasone modulate the effect of cannabidiol on the rat colon motility ex vivo
Chłopecka, M., Kiraga, Ł., Crowley, K., Jank, M., Latek, U., Mendel, M., & Karlik, W. (2023) · Journal of Veterinary Research · doi:10.2478/jvetres-2023-0029 · Cited by 3
“Many fast-acting effects of glucocorticoids are related to the limiting of cytokine activity (6).”
BackgroundBuckland, A. G., & Wilton, D. C. (2003) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-9214-7_14 · Cited by 3
[The kinome and glucocorticoid-induced apoptosis].
Sionov, R. V. (2008) · PubMed · Cited by 3
Immunomodulatory and Anti-Inflammatory Properties of Glucocorticoids
Ayroldi, E., Migliorati, G., & Riccardi, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00052-9 · Cited by 2
Grzanka, A., & Jarząb, J. (2009) · Advances in respiratory medicine · doi:10.5603/arm.27781 · Cited by 2
“[19] sugerują, że do tych oddziaływań przyczynia się niegenomowy mechanizm działania GK.”
Buttgereit, F., & Burmester, G. (2008) · Springer eBooks · doi:10.1007/978-0-387-68566-3_84 · Cited by 3
Anti-inflammatory glucocorticoids and annexin 1
Perretti, M., & Flower, R. J. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7506-5_8 · Cited by 1
“One example is linked to the externalisation of annexin 1, which occurs within the first 5–10 min post-GC exposure, and may differ among different GC [ 26 , 27].”
BackgroundSelf-citationThe Clinical Role of Glucocorticoids in the Management of Rheumatoid Arthritis
Al‐Mossawi, H., & John, R. (2012) · InTech eBooks · doi:10.5772/27481 · Cited by 1
“Some of the effects of GC occur within minutes of their administration especially at high intravenous doses (Croxtall et al., 2000).”
BackgroundInfluentialSignaling to Chromatin Minireview: Role of Kinases and Chromatin Remodeling in Progesterone
Vicent, G. P., Nacht, A. S., Zaurín, R., Ballaré, C., Clausell, J., & Beato, M. (2010) · Cited by 1
Buttgereit, F., & Burmester, G. (2008) · Springer eBooks · doi:10.1007/978-0-387-68566-3_42 · Cited by 1
Exploitation of steroids in coronavirus disease 2019: An overview
Punuri, S. V., Jangra, S., & Shaima, K. A. (2023) · D Y Patil Journal of Health Sciences · doi:10.4103/dypj.dypj_44_23 · Cited by 1
Corticosteroid Treatment in Septic Shock
Liu, J., Xing, Q., Pan, X., Zhang, S., Chen, D., & Annane, D. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2694-4823 · Cited by 1
The Use of Glucocorticoids in the Treatment of Acute Asthma Exacerbations
Abdullah, A. (2012) · InTech eBooks · doi:10.5772/53221 · Cited by 1
“…that some protein components associated with GRs complex, which are released upon GR ligation can inactivate cytosolic phospholipase 2 and therefore inhibit the production of arachidonic acid and downstream components like prostaglandins and leukotriens (Croxtall et al, 2000; Croxtall et al, 2002).”
BackgroundBehavioral Medical Epigenetics
Cox, O., & Lee, R. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803239-8.00008-9 · Cited by 4
Non-Surgical Regional Therapy for Osteoarthritis: An Update and Review of the Literature
Wilson-Morkeh, H., & Mackworth‐Young, C. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91458 · Cited by 1
Solito, E., Mulla, A., Flower, R. J., & Buckingham, J. C. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm1088 · Cited by 1
Self-citationMechanisms of Glucocorticoid Receptor Regulation of Gene Expression
Scoltock, A. B., & Cidlowski, J. A. (2011) · Wiley eBooks · doi:10.1002/9781118083222.ch6 · Cited by 1
Wehmeyer, L. (2010) · Open University of Cape Town (University of Cape Town) · Cited by 1
Traditionelle Therapien: Glukokortikoide, Azathioprin, Methotrexat, Hydroxyharnstoff
Belgi, G., & Friedmann, P. S. (2002) · H&G Zeitschrift für Hautkrankheiten · doi:10.1046/j.1439-0353.2002.02628.x · Cited by 1
Physiological and molecular features of glucocorticoid actions in the gastrointestinal tract
Reichardt, S. D. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5026
Zijn inhalatiecorticosteroïden minder werkzaam bij patiënten die (door)roken?
van Hal, P. T. W. (2008) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6591-3_5
Gene expression-based screening of inhibitors of signal transduction
Antipova, A. A. (2005) · DSpace@MIT (Massachusetts Institute of Technology)
Haine, A. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1041
Machado, I. D. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2013.tde-27022014-105135
Chapter 20 Hormonal Modulation of Autoimmune Diseases: Glucocorticoids
Bijlsma, J. W. J., Buttgereit, F., Cutolo, M., & da Silva, J. A. P. (2008) · Technical report · doi:10.1016/s1571-5078(07)00220-6 · Cited by 1
POLYMYOSITIS AND DERMATOMYOSITIS - INFLAMMATION, MUSCLE STRUCTURE & IMMUNOSUPPRESSIVE TREATMENT
Loell, I. (2012) · Figshare
Dionísio, E. J. (2011) · Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista)
Studies of glucocorticoid receptor interacting proteins
Widén, C. (2005) · Figshare
Transcriptional Regulation of The Porcine GnRH Receptor Gene by Glucocorticoids
Lee, C. (2013) · Lincoln (University of Nebraska)
T CELL SUBSETS AND DISEASE MECHANISMS IN INFLAMMATORY MYOPATHIES
Pandya, J. M. (2014) · Figshare
Hou, W., Guan, J., Lu, H., Dong, Q., Han, Y., & Zhang, R. (2015) · Journal of Ovarian Research · doi:10.1186/s13048-015-0144-4
RetractedGlucocorticoid Sensitivity in Rheumatoid Arthritis
Quax, R. A. M. (2013) · EUR Research Repository (Erasmus University Rotterdam)
Interactions between glucocorticoid metabolism and inflammation in obesity and insulin resistance.
Nixon, M. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Cardiac glycogen accumulation following dexamethasone is regulated by AMPK.
Puthanveetil, P., & Rodrigues, B. B. (2008) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(08)24166-3
“effects through which glucocorticoids bring about genomic and non-genomic outcomes (8, 10, 11).”
BackgroundModulation of folate receptor-α by glucocorticoid receptor and progesterone receptor.
Tran, T. (2005) · Europe PMC (PubMed Central)
Current perspectives Update on glucocorticoid action and resistance
Ito, K., Chung, K. F., Adcock, I. M., & Kingdom, U. (2006)
Shatnawi, A. A. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Naumann, L. (2005) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15181 · Cited by 3
“Es wird vermutet, dass dieser Mechanismus durch Kinasen wie src, die neben den Hitzeschockproteinen zusätzlich am Multi-Protein-Komplex des zytosolischen Glucocorticoidrezeptors assoziiert sind, vermittelt ist (Pratt 1998, Croxtall et al. 2000).”
BackgroundMitochondria and energetics stress : signaling pathways and cellular adaptations.
Desquiret‐Dumas, V., & Malthièry, Y. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Wehmeyer, L. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
Nagalski, A., & Kiersztan, A. (2010)
Brance, M. L., & Plantalech, L. (2014) · Revista Argentina de Reumatología · doi:10.47196/rar.v25i3.87 · Cited by 1
The impact of glucocorticoids upon the insulin sensitivity of skeletal muscle
Morgan, S. (2010) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Absence of Annexin I Expression in B-cell Non-Hodgkin’s Lymphomas and Cell Lines
Vishwanatha, J. K., Salazar, E., & Gopalakrishnan, V. K. (2005) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2005.00.00.1g
Metadata
- Authors
- Croxtall, J. D., Choudhury, Q., & Flower, R. J.
- Affiliations
- Queen Mary University of London (GB)
- Corresponding author
- Croxtall, Jamie D
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-05
- Volume
- 130
- Issue
- 2
- Pages
- 289-298
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572055
- OpenAlex
- W2076179697
- Cited by
- 332
- References
- 42
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 11 · 2017: 9 · 2016: 12 · 2015: 12 · 2014: 15 · 2013: 18 · 2012: 17
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoids, dexamethasone, epidermal growth factor receptor, Grb2, p21ras, Raf, ERK signaling, cytosolic phospholipase A2, arachidonic acid release, annexin A1, glucocorticoid receptor, receptor tyrosine kinase signaling, A549 cells
- MeSH terms
- Binding, Competitive, Dexamethasone, Enzyme Activation, Glucocorticoids, Humans, Phospholipases A, Phosphorylation, Protein Conformation, Proteins, Receptors, Glucocorticoid, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Annexin A1, MAP Kinase Signaling System, Adaptor Proteins, Signal Transducing, GRB2 Adaptor Protein, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.